Systemic hemodynamic, forearm vascular, renal, and humoral responses to sustained cardiopulmonary baroreceptor deactivation in well-compensated cirrhosis

Transjugular intrahepatic portosystemic shunt: Is it the ultimate solution for refractory ascites?

Volume expanders for spontaneous bacterial peritonitis: Are we comparing oranges with oranges?

Beta-blockers in cirrhosis: Friend and foe?

Transjugular intrahepatic portosystemic shunt for refractory ascites: Tipping the sodium balance

Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome

Hepatorenal syndrome: Is it truly the end of the road?

The ‘Gerstmann's Syndrome’ of transjugular intrahepatic portosystemic shunt: should it be the left or should it be the right

New challenge of hepatorenal syndrome: Prevention and treatment

The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis

The effect of misoprostol on indomethacin-induced renal dysfunction in well-compensated cirrhosis

The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites: Ochs A, Rossle M, Haag K, Hauenstein K-H, Deibert P, Siegerstetter V, Hounker M, et al. N

An advance in the treatment of portal hypertension?

CHEMISTRY-FOLIO-2015.docx

FIS Essay

Class Schema

Graph Tutorial

05696748